Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: A strategy toward nutritional approach to chemoprevention of gastric cancer

Current Pharmaceutical Design

Volumn 16, Issue 7, 2010, Pages 847-853

  Linsalata, M ^a   Cavallini, A ^a   Messa, C ^a   Orlando, A ^a   Refolo, M G ^a   Russo, F ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Chemoprevention; Gastric cancer; ODC; Polyamines; Probiotics; SSAT

Indexed keywords

MESSENGER RNA; ORNITHINE DECARBOXYLASE; POLYAMINE; PROBIOTIC AGENT; SPERMIDINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CATABOLISM; CELL GROWTH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; LACTOBACILLUS RHAMNOSUS; POLYAMINE METABOLISM; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; STOMACH CANCER;

ACETYLTRANSFERASES; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LACTOBACILLUS RHAMNOSUS; ORNITHINE DECARBOXYLASE; POLYAMINES; PROBIOTICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 77950285602     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790883598     Document Type: Article

References (48)

1. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009; 472: 467-477
2. Leung WK, Sung JJ. Chemoprevention of gastric cancer. Eur J Gastroenterol Hepatol 2006; 18: 867-871
3. Grau MV, Rees JR, Baron JA. Chemoprevention in gastrointestinal cancer: current status. Basic Clin Pharmacol Toxicol 2006; 98: 281-287
4. Dai Y, Wang WH. Non-steroidal anti-inflammatory drugs in prevention of gastric cancer. World J Gastroenterol 2006; 12: 2884-2889
5. Milner JA, McDonald SS, Anderson DE, Greenwald P. Molecular targets for nutrients involved with cancer prevention. Nutr Cancer 2001; 41: 1-16
6. MacFarlane AJ, Stover PJ. Convergence of genetic, nutritional and inflammatory factors in gastrointestinal cancers. Nutr Rev 2007; 65: S157-S66
7. Larsson SC, Bergkvist L, Wolk A. Fruit and vegetable consumption and incidence of gastric cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2006; 15: 1998-2001
8. Rafter J. Lactic acid bacteria and cancer: mechanistic perspective. Br J Nutr 2002; 88: S89-S94
9. Takagi A, Ikemura H, Matsuzaki T, Sato M, Nomoto K, Morotomi M, et al. Relationship between the in vitro response of dentric cells to Lactobacillus and prevention of tumorigenesis in the mouse. J Gastroenterol 2008; 43: 661-669
10. Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr 2001; 73: 465S-70S
11. De Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008; 111: 1-66
12. Choi SS, Kim Y, Han KS, You S, Oh S, Kim SH. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett Appl Microbiol 2006; 42: 452-458
13. Moinard C, Cynober L, de Bandt J-P. Polyamines: metabolism and implications in human diseases. Clin Nutr 2005; 24: 184-197
14. Thomas T , Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med 2003; 7: 113-126
15. Bachrach U. In: Nishioka K Ed, Polyamines in cancer: basic mechanisms and clinical approaches. Austin TE, RG Landes Co. 1996; pp. 45-60
16. Miao XP, Li JS, Li HY, Zeng SP, Zhao Y, Zeng JZ. Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions. World J Gastroenterol 2007; 13: 2867-2871
17. Shantz LM, Levin VA. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential. Amino Acids 2007; 33:213-223
18. Pegg AE. Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator. Am J Physiol Endocrinol Metab 2008; 294: E995-E1010.
19. Basuroy U K, Gerner E W. Emerging concept in targeting the polyamine metabolic pathway in epithelial cancer chemoprevention and chemotherapy. J Biochem 2006; 139: 27-33
20. Seiler N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr Drug Targets 2003; 4: 537-564
21. Seiler N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr Drug Targets 2003; 4: 565-585
22. Russo F, Orlando A, Linsalata M, Cavallini A, Messa C. Effects of Lactobacillus rhamnosus GG on the cell growth and polyamine metabolism in HGC-27 human gastric cancer cells. Nutr Cancer 2007; 59: 106-114
23. Linsalata M, Russo F, Berloco P, Caruso ML, Di Matteo G, Cifone MG, et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 2004; 9: 165-172
24. Garewall HS, Sloan D, Sampliner RE, Fennerty B. Ornithine decarboxylase assay in human colorectal mucosa: methodological issues of importance to quality control. Int J Cancer 1992; 52: 355-358
25. Wallace HM, Evans DM. Measurement of spermidine/spermine N1-acetyltransferase activity. In: Morgan DML Ed, Polyamine protocols. Totowa NJ, Humana Press Inc. 1998; pp. 59-68
26. Linsalata M, Giannini R, Notarnicola M, Cavallini A. Peroxi-some proliferator-activated receptor gamma and spermidine/ spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer. BMC Cancer 2006, 6: 191-197
27. Linsalata M, Caruso MG, Leo S, Guerra V, D'Attoma B, Di Leo A. Prognostic value of tissue polyamine levels in human colorectal carcinoma. Anticancer Res 2002; 22: 2465-2470
28. Gerner EW, Meyskens FL. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004; 4: 781-792
29. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular me chanisms and therapeutic applications. Cell Mol Life Sci 2001; 58: 244-258
30. Linsalata M, Russo F. Nutritional factors and polyamine metabolism in colorectal cancer. Nutrition 2008; 24: 382-389
31. Seiler N, Atanassov CL, Raul F. Polyamine metabolism as target for cancer chemoprevention. Int J Oncol 1998; 13: 993-1006
32. Pegg AE. Regulation of ornithine decarboxylase. J Biol Chem 2006; 281: 14529-14532
33. Bachrach U, Wang YC. Cancer therapy and prevention by green tea: role of ornithine decarboxylase. Amino Acids 2002; 22: 1-13
34. Wallace HM, Fraser AV. Inhibitors of polyamine metabolism: Review article. Amino Acids 2004; 26: 353-365
35. Allen WL, McLean EG, Boyer J, McCulla A, Wilson PM, Coyele V, et al. The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells. Mol Cancer Ther 2007; 6: 128-137
36. Babbar N, Gerner E, Casero RA. Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cells. Biochem J 2006; 394: 317-324
37. Schneider Y, Vincent F, Duranton B, Badolo L, Gosse F, Bergmann C, et al. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett 2000; 158: 85-91
38. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS. Bifidobacterium longum, a lactic acid-producing intestinal bacterium, inhibits colon cancer and modulates the intestinal biomarkers of colon carcinogenesis. Carcinogenesis 1997; 18: 833-841
39. Hector S, Tummala R, Kisiel ND, Diegelman P, Vujcic S, Clark K, et al. Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermine. Cancer Chemother Pharmacol 2008; 62: 517-527
40. Ignatenko NA, Besselsen DG, Stringer DE, Blohm-Mangone KA, Cui H, Gerner EW. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis. Nutr Cancer 2008; 60: S30-S35
41. Gerner EW, Meyskens FL Jr, Goldschmid S; Lance P, Pelot D. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention. Amino Acids 2007; 33: 189-195
42. Saxelin M, Salminen S, Isolauri E. Clinical efficacy of a human Lactobacillus strain as a probiotic in functional foods. In: Sadler MJ and Saltmarsh M Eds, The consumer, the Production and the Evidence. Cambridge, The Royal Soc. Chem. 1998
43. Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in human stomach and adhesion to intestinal cells. J Dairy Sci 1987; 70: 1-12
44. He F, Morita H, Ouwehand AC. Bifidobacteria and lactobacilli exhibited different mitogenic activity on murine splenocytes. Int J Probiotics Prebiotics 2006; 1: 77-82
45. Sütas Y, Soppi E, Korhonen H, Syväoja EL, Saxelin M, Rokka T. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolysed with Lactobacillus GG derived enzyme. J Allergy Clin Immunol 1996; 98: 216-224
46. Pessi T, Isolauri E, Sutas Y, Kankaanranta H, Moilanen E, Hurme M. Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein. Int Immunopharmacol 2001; 1: 211-218
47. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, et al. Immunomodulatory and antitumor effects in vivo by the cytoplasmatic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci 2004; 5: 41-48
48. Pessi T, Sutas Y, Saxelin M, Kallioinen H, Isolauri E. Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol 1999; 65: 4725-4728